Drug company Cephalon has sent out a Dear Doctor and a Dear Healthcare Professional letter about safe use of its cancer pain drug Fentora (fentanyl buccal tablet) which has been linked with four deaths recently. The letters, dated 10th September, remind pain management specialists and other healthcare professionals that Fentora should only be used to manage breakthrough pain in patients with cancer who are already taking, and are already known to be tolerant, to opioids (substances that act like morphine), for their underlying persistent cancer pain.
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment